Radioimmunotherapy of lymphoma using anti-CD20 antibodies
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Dec 1, 1998
Issued Date -
N/A
app pub date -
Apr 26, 1996
filing date -
Sep 16, 1993
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
Methods for the treatment of lymphoma by administration of a B cell-specific antibody are described. The invention encompasses providing to a patient both unlabeled antibodies and antibodies labeled with a radioisotope. A principal advantage of the method is that tumor responses can be obtained in a radiometric dose range that does not require hematopoietic stem cell replacement as an adjunct therapy.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully